Background
Methods
Search strategy and inclusion criteria
Data analysis
Risk of bias assessment
Results
Identification of studies
Characteristics of included studies
First author, year and reference | Country | Design study | Study duration | In patients/ outpatients | Number of patients | Age range | Adult/Children only | Sex | Duration of fever (mean duration) |
---|---|---|---|---|---|---|---|---|---|
Abhilash et al., 2016 [20] | India | Prospective observational study | 12 months | OPD + ED | 1258 | > 15 years | Adults + children | M = 680 F = 568 | 3–14 days |
Ahmad et al., 2016 [44] | India | Retrospective observational study | 12 months | IP | 298 | > 2 years | Adults + children | Not specified | AUFI |
Andrews et al., 2014 [45] | India | Retrospective and Patient admitted prospective study | 2 months | IP | 369 | > 13 years | Adults | F = 118 M = 251 | AUFI |
Arora et al., 2014 [46] | India | Retrospective study | 24 months | IP + OPD | 38,635 | All ages groups | Adult + Children | Not specified | AUF |
Capeding et al., 2013 [11] | Indonesia, Malaysia, Philippines, Thailand and Vietnam | Active fever surveillance, cohort study | 9.8 months | Community based | 289 | 2–14 years | Children | Not specified | < 14 days |
Chheng et al., 2013 [42] | Cambodia | Prospective study | 12 months | IP | 1225 | < 16 years | Children | M = 668 F = 557 | < 28 days |
Chikkaveerariah et al., 2016 [47] | India | Prospective observational study | 24 months | IP | 150 | > 14 years | Adults | F = 69 M = 81 | AUFI |
Chrispal et al., 2010 [1] | India | Prospective observational study | 12 months | IP | 398 | > 16 years Mean 39.5 | Adults | M = 239 F = 159 | 5–21 days |
Das et al., 2015 [48] | India | Cross-sectional study | 6 months | IP | 205 | All ages | Adults + Children | F = 89 M = 116 | Acute febrile illness |
Ellis et al., 2006 [49] | Thailand | Prospective study | 33 months | IP + OPD | 613 | 20–87 years | Adults | M = 325 F = 288 | Fever over previous 48 h and fever longer than 48 h cause of fever not yet known |
Gopalakrishnan et al., 2013 [21] | India | Prospective observational | 18 months | IP | 403 | > 16 years | Adults | M = 264 F = 139 | 5–14 days |
Joshi et al., 2008 [22] | India | Retrospective review of electronic discharge summaries | 6 months | IP | 1197 | > 12 years | Adults | M = 640 F = 557 | < 14 days |
Kammili et al., 2013 [23] | India | Prospective descriptive hospital based study | 2 months | IP | 100 | All ages | Both children and adults | Not specified | > 24 h |
Kashinkunti et al., 2013 [37] | India | Prospective observational | Not specified | IP | 100 | > 16 years | Adults | M = 58 F = 42 | < 15 days |
Kasper et al., 2012 [24] | Cambodia | Fever surveillance study | Not specified | OPD | 9997 | > 2 years Mean 19.6 Median 16.9 | Adults and children | M = 5398 F = 4599 | < 10 days |
Kumar et al., 2008 [39] | India | Prospective study | 12 months | OPD | 298 | 6 months −12 years | Children | M = 117 F = 181 | < 15 days |
Laoprasopwattana et al., 2012 [25] | Thailand | Prospective cohort study | 4 months | IP + OPD | 50 | 1 month −15 years | Children | Not specified | < 7 days |
Leelarasamee et at., 2004 [2] | Thailand | Prospective epidemiological study | 36 months | OPD | 1137 | > 2 years | Adults + Children | Not specified | < 1 day |
Mayxay et al., 2013 [26] | Laos | Prospective study | 30 months | IP + OPD | 1938 | 5–49 median 19 | Adults/children | M = 1124 F = 814 | < 8 days |
McGready et al., 2010 [50] | Thailand | Prospective cohort study | 28 months | IP | 409 | > 15 years | Pregnant females only | M = 467 F = 409 | Any fever |
Mittal et al., 2015 [51] | India | Retrospective observational study | 12 months | IP + OPD | 2547 | > 18 years | Adults | F = 884 M = 1663 | AUFI |
Murdoch et al., 2004 [36] | Nepal | Prospective study | 3 months | IP + OPD | 876 | > 14 years Median 27 | Adults | F = 409 | 24 h |
Oishr et al., 2006 [27] | Philippines | Prospective study | 24 months | IP | 503 | 2–17 years | Children | M = 298 F = 205 | < 5 days |
Phuong et al., 2006 [28] | Vietnam | Prospective study | 12 months | OPD | 2096 | All ages | Both children and adults | M = 1229 F = 865 | < 14 days |
Pradutkanchana et al., 2003 [7] | Thailand | Prospective study | 1 month | IP | 180 | Less than 15 years | Children | Not specified | < 21 days |
Punjabi et al., 2012 [43] | Indonesia | Prospective study | 27 months | IP | 226 | 1–80 years | Adults and children | M = 127 F = 99 | 1–30 days |
Rafizah et al., 2012 [52] | Malaysia | Hospital-based cross sectional study | 6 months | IP | 999 | > 18 years | Adults | F = 543 M = 456 | Acute fever |
Rani et al., 2016 [53] | India | Retrospective study | 6 Months | IP + OPD | 200 | All ages | Adults + children | F = 82 M = 118 | Acute febrile illness |
Ray et al., 2012 [29] | India | Prospective descriptive study | 12 months | IP + OPD | 540 | All age groups | Both children and adults | M = 329 F = 211 | < 7 days |
Reller et al., 2011 [31] | Sri Lanka | Prospective study | 8 months | IP + OPD | 773 | > 2 years | Both children and adults | M = 463 F = 310 | < 7 days |
Reller et al., 2012 [30] | Sri Lanka | Prospective study | 8 months | IP + OPD | 859 | > 2 years | Both children and adults | M = 526 F = 333 | < 7 days |
Sabchareon et al., 2012 [54] | Thailand | Prospective cohort study | 48 months | Community based + IP + OPD | 3401 | 3–15 years | Children | M = 1733 F = 1668 | All documented fever with school absenteeism |
Suttinont et al., 2006 [12] | Thailand | Prospective observational study in 5 hospitals | 12 months | IP | 845 | > 15 years Median 38 | Adults | M = 661 F = 184 | < 15 days |
Thompson et al., 2015 [56] | Nepal | Prospective study | 38 months | IP + OPD | 627 | > 2 years | Adults + children | Not specified | UFI |
Zaki et al., 2010 [41] | India | Prospective observational study | 4 months | IP | 602 | 1 month −12 years | Children | Not specified | < 21 days |
Kingston et al., 2018 [38] | Bangladesh | Prospective study | 12 months | IP | 416 | ≥12 years | Adults | Not specified | < 21 days |
Raina et al., 2018 [32] | India | Cohort study | 2 months | IP | 1164 | > 18 years | Adults | Not specified | ≤14 days |
Shelke et al., 2017 [33] | India | Prospective cross-sectional | 18 months | IP | 270 | All ages | Adults + children | M = 138 F = 132 | < 14 days |
Gautam et al., 2019 [57] | Nepal | Cross-sectional study | 12 months | IP | 1585 | > 1 year | Adult + children | M = 728 F = 757 | > 4 days |
Bodinayake et al., 2018 [35] | Sri Lanka | Prospective study | 12 months | IP | 976 | ≥1 years | Adults + children | M = 628 F = 348 | ≤3 days |
Salagre et al., 2017 [55] | India | Prospective observational study | 2 months | IP | 276 | > 13 years | Adults | M = 187 F = 89 | AFI |
Andrews et al., 2018 [34] | India | Prospective observational study | 12 months | IP | 1324 | > 13 years | Adults | M = 837 F = 487 | < 14 days |
Wangrangsimakul et al., 2018 [40] | Thailand | Prospective observational study | 27 months | IP | 200 | ≥15 years | Adults | M = 114 F = 86 | < 21 days |
Aetiology of AUFI by age group
Organism | Adults (n; %) | Children (n; %) | UAG (n; %) | Total⁑ (n; %) |
---|---|---|---|---|
Viral aetiologies | 2169 (18.6) | 1625 (23.8) | 11,094 (17.9) | 14,888 (18.5) |
Dengue | 1928 (16.6) | 1281 (18.7) | 6302 (10.2) | 9511 (11.8) |
JE*** | 5 (0.0) | 71 (1.0) | 233 (0.4) | 309 (0.4) |
Influenza** | 180 (1.5) | 48 (0.7) | 2286 (3.7) | 2514 (3.1) |
H1N1 | 5 (0.0) | 1 (0.0) | 513 (0.8) | 519 (0.6) |
Chikungunya | 15 (0.1) | 114 (1.7) | 326 (0.5) | 455 (0.6) |
Hepatitis A | 8 (0.1) | 7 (0.1) | 58 (0.1) | 73 (0.1) |
Hepatitis B | 5 (0.0) | 0 (0.0) | 267 (0.4) | 272 (0.3) |
Hepatitis E | 2 (0.0) | 0 (0.0) | 1038 (1.7) | 1040 (1.3) |
Flavi virus | 0 (0.0) | 65 (1.0) | 0 (0.0) | 65 (0.1) |
Para influenza 1 | 0 (0.0) | 10 (0.1) | 0 (0.0) | 10 (0.0) |
Para influenza 3 | 0 (0.0) | 28 (0.4) | 0 (0.0) | 28 (0.0) |
Hanta virus | 2 (0.0) | 0 (0.0) | 71 (0.1) | 73 (0.1) |
HIV | 19 (0.2) | 0 (0.0) | 0 (0.0) | 19 (0.0) |
Bacterial aetiologies | 3037 (26.1) | 435 (6.4) | 6912 (11.1) | 10,384 (12.9) |
Leptospirosis | 732 (6.3) | 88 (1.3) | 2729 (4.4) | 3549 (4.4) |
Typhoid | 696 (6.0) | 107 (1.6) | 2455 (4.0) | 3258 (4.0) |
Paratyphoid | 57 (0.5) | 0 (0.0) | 0 (0.0) | 57 (0.1) |
Rickettsiosis diseases | 1449 (12.5) | 140 (2.0) | 1654 (2.7) | 3243 (4.0) |
Scrub typhus | 1244 (10.7) | 103 (1.5) | 1512 (2.4) | 2859 (3.5) |
Murine typhus | 171 (1.5) | 0 (0.0) | 101 (0.2) | 272 (0.3) |
Spotted fever | 34 (0.3) | 37 (0.5) | 41 (0.1) | 112 (0.1) |
Q fever | 7 (0.1) | 0 (0.0) | 0 (0.0) | 7 (0.0) |
E coli | 11 (0.1) | 21 (0.3) | 26 (0.0) | 58 (0.1) |
Burkholderia pseudomallei | 3 (0.0) | 14 (0.2) | 6 (0.0) | 23 (0.0) |
Tuberculosis | 29 (0.2) | 6 (0.1) | 8 (0.0) | 43 (0.1) |
Klebsiella pneumoniae | 1 (0.0) | 0 (0.0) | 2 (0.0) | 3 (0.0) |
Haemophilus influenza | 0 (0.0) | 0 (0.0) | 9 (0.0) | 9 (0.0) |
Staph aureus | 0 (0.0) | 37 (0.5) | 12 (0.0) | 49 (0.1) |
Strep pneumoniae | 51 (0.4) | 18 (0.3) | 6 (0.0) | 75 (0.1) |
Strep Gr A | 0 (0.0) | 0 (0.0) | 2 (0.0) | 2 (0.0) |
Strep Gr C | 0 (0.0) | 0 (0.0) | 1 (0.0) | 1 (0.0) |
Neisseria meningitis | 1 (0.0) | 4 (0.1) | 2 (0.0) | 7 (0.0) |
Protozoa | 1139 (9.8) | 57 (0.8) | 1085 (1.7) | 2281 (2.8) |
Malaria | 1139 (9.8) | 57 (0.8) | 1085 (1.7) | 2281 (2.8) |
Fungal aetiologies | 0 (0.0) | 0 (0.0) | 3 (0.0) | 3 (0.0) |
Yeast non-Cryptococci | 0 (0.0) | 0 (0.0) | 2 (0.0) | 2 (0.0) |
Cryptococcus neoformans | 0 (0.0) | 0 (0.0) | 1 (0.0) | 1 (0.0) |
Co infections | 251 (2.2) | 30 (0.4) | 700 (1.1) | 981 (1.2) |
Co infection* | 226 (1.9) | 30 (0.4) | 484 (0.8) | 740 (0.9) |
Co infection† | 25 (0.2) | 0 (0.0) | 210 (0.3) | 235 (0.3) |
Co infection‡ | 0 (0.0) | 0 (0.0) | 6 (0.0) | 6 (0.0) |
Unknown/others | 5036 (43.3) | 4693 (68.6) | 42,274 (68.1) | 52,003 (64.6) |
Deaths | 125 (33.1) | 81 (21.4) | 172 (45.5) | 378 (100.0) |
Aetiology of AUFI by site of patient recruitment
Organism | IP (n; %) | OP (n; %) | OP+IP (n; %) | Total (n; %) |
---|---|---|---|---|
Viral aetiologies | 2721 (18.8) | 5536 (36.7) | 6631 (13.0) | 14,888 (18.5) |
Dengue | 2377 (16.4) | 1277 (8.5) | 5857 (11.5) | 9511 (11.8) |
JE*** | 77 (0.5) | 7 (0.0) | 225 (0.4) | 309 (0.4) |
Influenza** | 86 (0.6) | 2077 (13.8) | 351 (0.7) | 2514 (3.1) |
HINI | 6 (0.0) | 513 (3.4) | 0 (0.0) | 519 (0.6) |
Chikungunya | 54 (0.4) | 224 (1.5) | 177 (0.3) | 455 (0.6) |
Hepatitis A | 0 (0.0) | 62 (0.4) | 11 (0.0) | 73 (0.1) |
Hepatitis B | 4 (0.0) | 267 (1.8) | 1 (0.0) | 272 (0.3) |
Hepatitis E | 2 (0.0) | 1038 (6.9) | 0 (0.0) | 1040 (1.3) |
Flavi virus | 65 (0.4) | 0 (0.0) | 0 (0.0) | 65 (0.1) |
Para influenza 1 | 10 (0.1) | 0 (0.0) | 0 (0.0) | 10 (0.0) |
Para influenza 3 | 28 (0.2) | 0 (0.0) | 0 (0.0) | 28 (0.0) |
Hanta virus | 1 (0.0) | 71 (0.5) | 1 (0.0) | 73 (0.1) |
HIV | 11 (0.1) | 0 (0.0) | 8 (0.0) | 19 (0.0) |
Bacterial aetiologies | 3340 (23.1) | 3383 (22.4) | 3662 (7.2) | 10,385 (12.9) |
Leptospirosis | 989 (6.8) | 2090 (13.9) | 470 (0.9) | 3549 (4.4) |
Typhoid | 406 (2.8) | 912 (6.0) | 1940 (3.8) | 3258 (4.0) |
Paratyphoid | 57 (0.4) | 0 (0.0) | 0 (0.0) | 57 (0.1) |
Rickettsial diseases | 1670 (11.6) | 341 (2.3) | 1232 (2.4) | 3243 (4.0) |
Scrub typhus | 1449 (10.0) | 245 (1.6) | 1165 (2.3) | 2859 (3.5) |
Murine typhus | 178 (1.2) | 65 (0.4) | 29 (0.1) | 272 (0.3) |
Spotted fever | 43 (0.3) | 31 (0.2) | 38 (0.1) | 112 (0.1) |
Q fever | 7 (0.0) | 0 (0.0) | 0 (0.0) | 7 (0.0) |
E coli | 29 (0.2) | 25 (0.2) | 4 (0.0) | 58 (0.1) |
Burkholderia pseudomallei | 17 (0.1) | 3 (0.0) | 3 (0.0) | 23 (0.0) |
Tuberculosis | 36 (0.2) | 0 (0.0) | 7 (0.0) | 43 (0.1) |
Klebsiella pneumonia | 2 (0.0) | 0 (0.0) | 2 (0.0) | 4 (0.0) |
Haemophilus influenza | 9 (0.1) | 0 (0.0) | 0 (0.0) | 9 (0.0) |
Staph aureus | 39 (0.3) | 8 (0.1) | 2 (0.0) | 49 (0.1) |
Strep pneumonia | 73 (0.5) | 2 (0.0) | 0 (0.0) | 75 (0.1) |
Strep Gr A | 1 (0.0) | 0 (0.0) | 1 (0.0) | 2 (0.0) |
Strep Gr C | 0 (0.0) | 0 (0.0) | 1 (0.0) | 1 (0.0) |
Neisseria meningitis | 5 (0.0) | 2 (0.0) | 0 (0.0) | 7 (0.0) |
Protozoa | 990 (6.9) | 57 (0.4) | 1234 (2.4) | 2281 (2.8) |
Malaria | 990 (6.9) | 57 (0.4) | 1234 (2.4) | 2281 (2.8) |
Fungal aetiologies | 3 (0.0) | 0 (0.0) | 0 (0.0) | 3 (0.0) |
Yeast non-Cryptococci | 2 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.0) |
Cryptococcus neoformans | 1 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.0) |
Co infections | 343 (2.4) | 176 (1.2) | 496 (1.0) | 1015 (1.3) |
Co infection* | 331 (2.3) | 169 (1.1) | 270 (0.5) | 770 (1.0) |
Co infection† | 12 (0.1) | 7 (0.0) | 220 (0.4) | 239 (0.3) |
Co infection‡ | 0 (0.0) | 0 (0.0) | 6 (0.0) | 6 (0.0) |
Unknown | 7053 (48.8) | 5923 (39.3) | 39,036 (76.5) | 52,012 (64.5) |
Deaths | 270 (71.4) | 30 (7.9) | 78 (20.6) | 378 (100.0) |
Aetiology of AUFI by region
Organism | SEA (n; %) | South Asia (n; %) | Total (n; %) |
---|---|---|---|
Viral aetiologies | 7828 (33.0) | 7060 (12.4) | 14,888 (18.5) |
Dengue | 2690 (11.4) | 6821 (12.0) | 9511 (11.8) |
JE*** | 309 (1.3) | 0 (0.0) | 309 (0.4) |
Influenza** | 2511 (10.6) | 3 (0.0) | 2514 (3.1) |
HINI | 514 (2.2) | 5 (0.0) | 519 (0.6) |
Chikungunya | 256 (1.1) | 199 (0.3) | 455 (0.6) |
Hepatitis A | 62 (0.3) | 11 (0.0) | 73 (0.1) |
Hepatitis B | 267 (1.1) | 5 (0.0) | 272 (0.3) |
Hepatitis E | 1038 (4.4) | 2 (0.0) | 1040 (1.3) |
Flavi virus | 65 (0.3) | 0 (0.0) | 65 (0.1) |
Para influenza 1 | 10 (0.0) | 0 (0.0) | 10 (0.0) |
Para influenza 3 | 28 (0.1) | 0 (0.0) | 28 (0.0) |
Hanta virus | 71 (0.3) | 2 (0.0) | 73 (0.1) |
HIV | 7 (0.0) | 12 (0.0) | 19 (0.0) |
Bacterial aetiologies | 4873 (20.6) | 5512 (9.7) | 10,385 (12.9) |
Leptospirosis | 2861 (12.1) | 688 (1.2) | 3549 (4.4) |
Typhoid | 809 (3.4) | 2449 (4.3) | 3258 (4.0) |
Paratyphoid | 0 (0.0) | 57 (0.1) | 57 (0.1) |
Rickettsial diseases | 1009 (4.3) | 2234 (3.9) | 3243 (4.0) |
Scrub typhus | 764 (3.2) | 2095 (3.7) | 2859 (3.5) |
Murine typhus | 146 (0.6) | 126 (0.2) | 272 (0.3) |
Spotted fever | 99 (0.4) | 13 (0.0) | 112 (0.1) |
Q fever | 7 (0.0) | 0 (0.0) | 7 (0.0) |
E coli | 49 (0.2) | 9 (0.0) | 58 (0.1) |
Burkholderia pseudomallei | 23 (0.1) | 0 (0.0) | 23 (0.0) |
Tuberculosis | 21 (0.1) | 22 (0.0) | 43 (0.1) |
Klebsiella pneumoniae | 3 (0.0) | 1 (0.0) | 4 (0.0) |
Haemophilus influenza | 9 (0.0) | 0 (0.0) | 9 (0.0) |
Staph aureus | 49 (0.2) | 0 (0.0) | 49 (0.1) |
Strep pneumoniae | 24 (0.1) | 51 (0.1) | 75 (0.1) |
Strep Gr A | 2 (0.0) | 0 (0.0) | 2 (0.0) |
Strep Gr C | 1 (0.0) | 0 (0.0) | 1 (0.0) |
Neisseria meningitides | 6 (0.0) | 1 (0.0) | 7 (0.0) |
Protozoa | 559 (2.4) | 1722 (3.0) | 2281 (2.8) |
Malaria | 559 (2.4) | 1722 (3.0) | 2281 (2.8) |
Fungal aetiologies | 3 (0.0) | 0 (0.0) | 3 (0.0) |
Yeast non Cryptococci | 2 (0.0) | 0 (0.0) | 2 (0.0) |
Cryptococcus neoformans | 1 (0.0) | 0 (0.0) | 1 (0.0) |
Co infections | 815 (3.4) | 196 (0.3) | 1011 (1.3) |
Co infection* | 592 (2.5) | 178 (0.3) | 770 (1.0) |
Co infection† | 217 (0.9) | 18 (0.0) | 235 (0.3) |
Co infection‡ | 6 (0.0) | 0 (0.0) | 6 (0.0) |
Unknown | 9621 (40.6) | 42,389 (74.5) | 52,010 (64.5) |
Deaths | 114 (30.2) | 264 (69.8) | 378 (100.0) |